Seeking Alpha

Roche (RHHBY.OB): Q1 sales +5.1% to 11.6B Swiss francs ($12.4B), above consensus of 11.5B...

Roche (RHHBY.OB): Q1 sales +5.1% to 11.6B Swiss francs ($12.4B), above consensus of 11.5B francs. Pharmaceuticals sales +7% to 9.2B francs, diagnostics +1% to 2.4B francs; Herceptin (breast cancer) 1.57B francs; Tamiflu +84% to 335M francs, due to severe flu season in U.S. Reiterates that 2013 sales will rise at same rate as in 2012, while core EPS will increase faster than revenues. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)